TrialClinical rheumatology2017
Efficacy and safety of long-term treatment with low-dose rituximab for relapsing mixed cryoglobulinemia vasculitis.
Stefania Colantuono et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this paperpooled itcites it